SBFM DEF 14A: Board change
Sunshine Biopharma
Filed with the SEC on · accession 0001683168-26-008615
SBFM filed a DEF 14A (proxy statement) with the SEC on Nov 12, 2026. Information for the shareholder meeting: votes, board members and executive pay. The stock moved +3.3% by the first close after the filing.
Summary of the filing
Sunshine Biopharma filed a definitive proxy statement for its 2026 annual meeting, asking shareholders to elect five directors, ratify M&K CPAS as auditor, and approve an increase in shares authorized under its 2023 Equity Incentive Plan to 7,000,000.
Key details
How SBFM stock reacted
Close before
$2.75
Nov 11, 2026
First close after
+3.27%
$2.84
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for SBFM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SBFM?
Click hereFrequently asked questions
What did SBFM file with the SEC on Nov 12, 2026?
SBFM filed a DEF 14A (Board change). Sunshine Biopharma filed a definitive proxy statement for its 2026 annual meeting, asking shareholders to elect five directors, ratify M&K CPAS as auditor, and approve an increase in shares authorized under its 2023 Equity Incentive Plan to 7,000,000.
What does a board change mean for SBFM stock?
Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.
How do I read a DEF 14A?
Information for the shareholder meeting: votes, board members and executive pay. Executive pay tables show how management is paid. Check the items shareholders vote on (mergers, new share plans).
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A DEF 14A (proxy statement): Information for the shareholder meeting: votes, board members and executive pay.
How did SBFM stock react to this filing?
SBFM closed at $2.75 before the filing and $2.84 on Nov 12, 2026 (+3.27%).
Other SBFM SEC filings
- 10-Q · SEC filingNov 12, 2026
- SCHEDULE 13G/A · SEC filingNov 10, 2026
- 8-K · SEC filingOct 14, 2026
- SCHEDULE 13G · SEC filingOct 14, 2026
- SCHEDULE 13G · SEC filingOct 13, 2026
- 424B4 · Secondary offeringOct 9, 2026
- 8-K · SEC filingOct 9, 2026
- EFFECT · Shelf registrationOct 7, 2026
- SCHEDULE 13G/A · SEC filingOct 5, 2026
- S-1 · Shelf registrationOct 2, 2026
Get alerts when SBFM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days